A Genomics ETF at the Center of the Coronavirus Fight
June 18, 2020 at 12:21 PM EDT
In the scramble to develop a Coronavirus vaccine, genomics investments are receiving renewed attention and rewarding investors in the process. Those sentiments are applicable to the Global X Genomics & Biotechnology ETF (Nasdaq: GNOM), which is higher by more than 52% in the current quarter....
